Healthequity Inc (NASDAQ:HQY) Director Frank Medici sold 13,000 shares of Healthequity stock in a transaction on Wednesday, November 29th. The shares were sold at an average price of $52.14, for a total transaction of $677,820.00. Following the completion of the sale, the director now directly owns 6,381 shares in the company, valued at approximately $332,705.34. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Frank Medici also recently made the following trade(s):

  • On Friday, November 24th, Frank Medici sold 7,540 shares of Healthequity stock. The shares were sold at an average price of $51.42, for a total transaction of $387,706.80.
  • On Tuesday, November 21st, Frank Medici sold 58,481 shares of Healthequity stock. The shares were sold at an average price of $51.25, for a total transaction of $2,997,151.25.
  • On Wednesday, November 15th, Frank Medici sold 700 shares of Healthequity stock. The stock was sold at an average price of $51.05, for a total transaction of $35,735.00.
  • On Friday, November 3rd, Frank Medici sold 32,404 shares of Healthequity stock. The stock was sold at an average price of $51.09, for a total transaction of $1,655,520.36.
  • On Monday, November 6th, Frank Medici sold 419,504 shares of Healthequity stock. The stock was sold at an average price of $52.97, for a total transaction of $22,221,126.88.
  • On Tuesday, October 24th, Frank Medici sold 7,900 shares of Healthequity stock. The stock was sold at an average price of $51.11, for a total transaction of $403,769.00.
  • On Monday, October 9th, Frank Medici sold 316,644 shares of Healthequity stock. The stock was sold at an average price of $51.96, for a total transaction of $16,452,822.24.

Shares of Healthequity Inc (NASDAQ HQY) traded down $0.41 on Friday, reaching $51.46. 380,985 shares of the company traded hands, compared to its average volume of 414,602. The stock has a market cap of $3,137.55, a price-to-earnings ratio of 82.33, a P/E/G ratio of 2.27 and a beta of 1.75. Healthequity Inc has a 12-month low of $37.62 and a 12-month high of $55.31.

Healthequity (NASDAQ:HQY) last issued its quarterly earnings data on Tuesday, September 5th. The company reported $0.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.14 by $0.13. The firm had revenue of $56.90 million for the quarter, compared to analyst estimates of $55.66 million. Healthequity had a net margin of 20.27% and a return on equity of 13.93%. Healthequity’s revenue was up 28.7% on a year-over-year basis. During the same period in the previous year, the firm earned $0.16 EPS. equities analysts predict that Healthequity Inc will post 0.7 EPS for the current year.

Institutional investors and hedge funds have recently modified their holdings of the stock. Alps Advisors Inc. increased its stake in Healthequity by 0.3% during the second quarter. Alps Advisors Inc. now owns 10,729 shares of the company’s stock worth $535,000 after purchasing an additional 28 shares during the period. Albion Financial Group UT increased its stake in Healthequity by 1.4% during the second quarter. Albion Financial Group UT now owns 8,694 shares of the company’s stock worth $433,000 after purchasing an additional 120 shares during the period. Oppenheimer Asset Management Inc. increased its stake in Healthequity by 7.7% during the second quarter. Oppenheimer Asset Management Inc. now owns 2,686 shares of the company’s stock worth $134,000 after purchasing an additional 191 shares during the period. Arizona State Retirement System increased its stake in Healthequity by 0.9% during the second quarter. Arizona State Retirement System now owns 23,097 shares of the company’s stock worth $1,151,000 after purchasing an additional 200 shares during the period. Finally, Louisiana State Employees Retirement System increased its stake in Healthequity by 1.1% during the second quarter. Louisiana State Employees Retirement System now owns 18,100 shares of the company’s stock worth $902,000 after purchasing an additional 200 shares during the period. Hedge funds and other institutional investors own 98.62% of the company’s stock.

Several equities research analysts have issued reports on HQY shares. Zacks Investment Research cut shares of Healthequity from a “buy” rating to a “hold” rating in a research note on Wednesday, November 15th. BidaskClub cut shares of Healthequity from a “hold” rating to a “sell” rating in a research note on Wednesday, October 18th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $56.00 target price on shares of Healthequity in a research note on Tuesday, September 5th. Finally, Robert W. Baird reiterated a “hold” rating on shares of Healthequity in a report on Thursday, September 21st. Three investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $57.50.

TRADEMARK VIOLATION NOTICE: “Healthequity Inc (HQY) Director Frank Medici Sells 13,000 Shares” was originally published by Daily Political and is owned by of Daily Political. If you are accessing this news story on another publication, it was illegally stolen and republished in violation of international trademark & copyright law. The correct version of this news story can be read at https://www.dailypolitical.com/2017/12/02/healthequity-inc-hqy-director-frank-medici-sells-13000-shares.html.

Healthequity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Insider Buying and Selling by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity Inc and related companies with MarketBeat.com's FREE daily email newsletter.